Skip to main content
HR 4769 116th Congress House Health Administrative remedies Advisory bodies Department of Health and Human Services Medicare Prescription drugs Public contracts and procurement

Medicare Prescription Drug Savings and Choice Act of 2019

Introduced: October 21, 2019 Introduced by: Schakowsky, Janice D. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 22, 2019
Referred to the Subcommittee on Health.
Oct 21, 2019
Introduced in House
Oct 21, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Plain-English summary Congressional Research Service

Medicare Prescription Drug Savings and Choice Act of 2019

This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish at least one prescription drug plan that is operated by Medicare.

Among other things, the plan must (1) serve the entire United States; and (2) be the default plan for enrollees under the Medicare prescription drug benefit, unless the enrollee chooses another plan.

Additionally, the CMS must negotiate prices for prescription drugs that are covered under the plan and, if appropriate, encourage the use of more affordable therapeutic equivalents. (Currently, the CMS is prohibited from negotiating the prices of covered drugs under the Medicare prescription drug benefit.) The Agency for Healthcare Research and Quality must assess the clinical benefits of drugs and make recommendations to the CMS regarding price negotiations, based on specified information (e.g., comparable international prices).

What's happening now October 22, 2019

Referred to the Subcommittee on Health.

 Committees of jurisdiction 3